Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bulycheva

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Gigiena I Sanitariia|October 1, 1984
[Determination of the fungicide bailetone in water by thin-layer chromatography]G N Bulycheva
Gigiena Truda I Professional'Nye Zabolevaniia|April 1, 1985
[Determination of the fungicide Bayleton in the air by thin-layer chromatography]G N Bulycheva
Georgian Medical News|March 4, 2021
PROVISION OF THE RIGHT TO NON-INTERFERENCE WITH PRIVACY DURING MUSTER PROCESS WITH THE PARTICIPATION OF DOCTOR (FORENSIC EXPERT)L Deshko, Zh Udovenko, N Bulycheva, et al.
Case Reports in Hematology|May 8, 2015
Rare form of erdheim-chester disease presenting with isolated central skeletal lesions treated with a combination of alfa-interferon and zoledronic AcidE N Bulycheva, V V Baykov, M I Zaraĭskiĭ, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Gigiena I Sanitariia|October 1, 1984
[Determination of the fungicide bailetone in water by thin-layer chromatography]G N Bulycheva
Gigiena Truda I Professional'Nye Zabolevaniia|April 1, 1985
[Determination of the fungicide Bayleton in the air by thin-layer chromatography]G N Bulycheva
Georgian Medical News|March 4, 2021
PROVISION OF THE RIGHT TO NON-INTERFERENCE WITH PRIVACY DURING MUSTER PROCESS WITH THE PARTICIPATION OF DOCTOR (FORENSIC EXPERT)L Deshko, Zh Udovenko, N Bulycheva, et al.
Case Reports in Hematology|May 8, 2015
Rare form of erdheim-chester disease presenting with isolated central skeletal lesions treated with a combination of alfa-interferon and zoledronic AcidE N Bulycheva, V V Baykov, M I Zaraĭskiĭ, et al.
Pageof 1